Wholesale Custom peptide vials weight loss products Tirzepatide 2024 Local Warehouse

Tirzepatide

Tirzepatide is an investigational once-weekly, dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist that integrates the actions of both incretins into a single molecule.

WhatsApp:+85256824722

Telegram:+85256824722

Tirzepatide Mimics Natural Hormones that Foster Feeling Full
Tirzepatide works by mimicking the GLP-1 and GIP hormones that are naturally secreted by the intestine after a meal, which prompts insulin secretion. It also reduces appetite by slowing down the time it takes the stomach to empty and interacting with areas in the brain harboring GLP-1 receptors to signal satiety.

Tirzepatide is a novel medication that is FDA approved for the treatment of type 2 diabetes mellitus. Given its potent weight loss properties, tirzepatide be used off-label for obesity treatment. It works as a dual GLP-1 agonist and GIP agonist to maximize similar benefits that are seen with GLP-1 medications such as semaglutide. It is currently implemented as a second-line diabetes medication, similar to GLP-1 medications, and given as a once-a-week subcutaneous injectable.

Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) recepto agonist, which is FDA-approved for treating type 2 diabetes mellitus. It is important to note that tirzepatide is not approved for treating type-1 diabetes mellitus and has not been studied in patients with pancreatitis. Tirzepatide is a GIP receptor and GLP-1 receptor agonist, leading to significantly improved glycemic control in type 2 diabetics and significant weight reduction.

The FDA approved Tirzepatide in May 2022. Tirzepatide can also be used off-label for treating obesity. It is currently implemented as a second-line diabetes medication, similar to GLP-1 medications like semaglutide. It is a once-a-week subcutaneous injectable medication with incremental dose increases.

Current clinical data has demonstrated that tirzepatide is superior to placebo in improving hemoglobin A1C levels. The SURPASS-5 clinical trial showed a -2.11% reduction in hemoglobin A1C levels at 5mg per week dosing, compared to -0.86% with placebo. At the highest dose of 15 mg per week, tirzepatide led to a -2.34% reduction in hemoglobin A1C. This was demonstrated over 40 weeks. A weight reduction of 5.4 kg was seen with 5mg of tirzepatide dosing, and a 10.5 kg reduction was seen with 15 mg dosing. This dose-dependent correlation with weight loss is similar to semaglutide, a common GLP-1 medication utilized for weight loss management.

Products Name:
Tirzepatide
CAS No.: 2023788-19-2
Purity: 99%
Appearance: White Lyophilized powder
Logo printing: Available
Storage: Cool Dry Place

jintropin hygetropin AOD9604 Hcg    HGH
fragment CJC-1295
TB-500  BPC-157  PT-141 Retatrutide  semaglutide Tirzepatide
CHRP-2  CHRP-6  Melanotan  peg-mgf  oxytocin   Ipamorelin
MGF  DSIP  Sermorelin  Hexarelin  Gonadorelin  Selank
Epithalon  Tesamorelin  Triptorelin  igf Ir3 f ollistatin 344  GHK-CU
dihexa  adipotide  Kisspeptin  semax  MOTS-C

Besides, you can contact us if you have any other questions

Q1: Can i get some samples?

A: Yes, we can supply the free sample, but the shipping cost be paid by our customers.

Q2: How to start orders or make payments?

A: Proforma invoice will be sent first after confirmation of order, enclosed our bank information. Payment by T/T, Western Unionor Paypal or Escrow(Alibaba).

Q3: How to confirm the Product Quality before placing orders?

A:You can get free samples for some products,you only need to pay the shipping costor arrange a courier to us and take the samples. You can send us your product specifi-cations and requests,we will manufacture the products according to your requests.

Q4:What’s your MOQ?

A:Our MOQ is 1kg. But usually we accept less quantity such as 100g on the conditionthat sample charge is 100% paid.

Q5: How about delivery lead time?

A: Delivery lead time: About 1-3 days after payment confirmed. (Chinese holiday notincluded)